+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Paratek Pharmaceuticals - logo

Paratek Pharmaceuticals is a biopharmaceutical company that focuses on the development and commercialization of therapeutics based upon tetracycline chemistry. Its lead product candidates include Omadacycline and Sarecycline, both of which are undergoing clinical trials. It has collaborative research and license agreement with Allergan plc to research and develop tetracycline products. Paratek was incorporated in 2001 and is based in Boston, Massachusetts.

From
From
From
Global Lifestyle Drugs Market 2017-2021 - Product Thumbnail Image

Global Lifestyle Drugs Market 2017-2021

  • Report
  • February 2017
  • 91 pages
From
From
From
From
Nuzyra 2019 U.S. Promotional Audit Report - Product Thumbnail Image

Nuzyra 2019 U.S. Promotional Audit Report

  • Report
  • July 2020
  • 32 pages
From
From
Urinary Tract Infections - Pipeline Insight, 2020 - Product Thumbnail Image

Urinary Tract Infections - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Gonorrhea - Pipeline Review, H2 2020 - Product Thumbnail Image

Gonorrhea - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 130 pages
From
Gonorrhea R&D Pipeline Analysis Report, Q4 2020 - Product Thumbnail Image

Gonorrhea R&D Pipeline Analysis Report, Q4 2020

  • Report
  • October 2020
  • 94 pages
From
From
Community Acquired Pneumonia - Pipeline Review, H2 2020 - Product Thumbnail Image

Community Acquired Pneumonia - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 170 pages
From
Community Acquired Pneumonia - Pipeline Insight, 2020 - Product Thumbnail Image

Community Acquired Pneumonia - Pipeline Insight, 2020

  • Drug Pipelines
  • February 2020
  • 106 pages
From
Loading Indicator
adroll